Translational Post-doctoral Training in Neurodevelopment
神经发育转化博士后培训
基本信息
- 批准号:9279441
- 负责人:
- 金额:$ 14.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract:
The Translational Post-doctoral Training in Neurodevelopment (TPND) Program at Boston Children's Hospital
is designed to provide promising post-doctoral neuroscience investigators (MD, PhD or MD/PhD) with
advanced training in essential translational topics ranging from preclinical considerations through
implementation of clinical trials for individuals with a range neurodevelopmental disorders. Large numbers of
children, adolescents, and adults are affected by neurodevelopmental disorders that begin early in life, are
rooted in aberrant brain circuitry, and have profound short- and long-term consequences on critical domains of
development, cognition, social interaction, and behavioral regulation; yet most available medical and
psychological treatments have had limited impact on the course of neurodevelopmental disorders. We
propose to build on the significant strengths of the Translational Neuroscience Center (TNC) and the
Laboratories of Cognitive Neuroscience at Boston Children's Hospital and Harvard Medical School to provide
trainees with research experiences ranging from pre-clinical and cognitive neuroscience labs through clinical
trial involvement in neurodevelopmental disorders. In addition, a key premise of this program is that effective
research training in the field of translational neuroscience requires both mentors with expertise in areas across
the continuum of translational research with neurodevelopmental disorders and ongoing programs to support
the trainees to conduct innovative, high impact translational research. The 17 faculty mentors will involve
trainees over a 2 year period (2 new entrants per year) with a range of state of the art methods in translational
neurodevelopmental science that reflect core areas of the TNC program including basic science and
translational methods as well as application to clinical populations in therapeutic trials for neurodevelopmental
disorders. This research experience will be supplemented with both didactic and clinical immersion
experiences designed to provide trainees with the skills needed to be successful independent investigators in
this critical and emerging field. Ultimately this research experience will yield treatments that have an impact on
the field by reducing the burdens and costs of care and costs to society that is now associated with
neurodevelopmental disorders. In addition, the TPND will develop models of interdisciplinary research training
for promising young scientists that will have a transformative impact on the field.
项目摘要/摘要:
波士顿儿童医院神经发育博士后转化培训 (TPND) 项目
旨在为有前途的博士后神经科学研究人员(MD、PhD 或 MD/PhD)提供
重要转化主题的高级培训,从临床前考虑到
对患有一系列神经发育障碍的个体进行临床试验。大量
儿童、青少年和成人都受到生命早期开始的神经发育障碍的影响,
植根于异常的大脑回路,并对关键领域产生深远的短期和长期影响
发展、认知、社会互动和行为调节;但大多数可用的医疗和
心理治疗对神经发育障碍的病程影响有限。我们
建议利用转化神经科学中心(TNC)和
波士顿儿童医院和哈佛医学院的认知神经科学实验室提供
具有从临床前和认知神经科学实验室到临床研究经验的学员
尝试参与神经发育障碍。此外,该计划的一个关键前提是有效
转化神经科学领域的研究培训需要两位具有跨领域专业知识的导师
神经发育障碍转化研究的连续性和正在进行的支持计划
学员进行创新、高影响力的转化研究。 17名教师导师将包括
为期 2 年的受训人员(每年 2 名新学员)接受一系列最先进的转化方法
反映 TNC 项目核心领域的神经发育科学,包括基础科学和
转化方法以及在神经发育治疗试验中对临床人群的应用
失调。这种研究经验将通过教学和临床沉浸得到补充
旨在为学员提供成为成功的独立调查员所需的技能的经验
这个关键的新兴领域。最终,这项研究经验将产生对以下疾病产生影响的治疗方法:
通过减少目前与护理相关的负担和成本以及社会成本来推动这一领域
神经发育障碍。此外,TPND 将开发跨学科研究培训模型
奖励将对该领域产生变革性影响的有前途的年轻科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES Alexander NELSON其他文献
CHARLES Alexander NELSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES Alexander NELSON', 18)}}的其他基金
Predicting ASD and Other Developmental Outcomes in the First Year of Life Using EEG in a Diverse Community-based Sample (Administrative Supplement)
在基于不同社区的样本中使用脑电图预测生命第一年的自闭症谱系障碍和其他发育结果(行政补充)
- 批准号:
10840167 - 财政年份:2021
- 资助金额:
$ 14.08万 - 项目类别:
Predicting ASD and Other Developmental Outcomes in the First Year of Life Using EEG in a Diverse Community-Based Sample
在基于不同社区的样本中使用脑电图预测生命第一年的自闭症谱系障碍和其他发育结果
- 批准号:
10535487 - 财政年份:2021
- 资助金额:
$ 14.08万 - 项目类别:
Predicting ASD and other developmental outcomes in the first year of life using EEG in a diverse community-based sample
使用脑电图在基于不同社区的样本中预测生命第一年的自闭症和其他发育结果
- 批准号:
10360759 - 财政年份:2021
- 资助金额:
$ 14.08万 - 项目类别:
4/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
4/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
- 批准号:
9898607 - 财政年份:2019
- 资助金额:
$ 14.08万 - 项目类别:
4/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes (Administrative Supplement)
4/5 物质暴露和早期生活逆境对儿童健康发展和结果的累积风险(行政补充)
- 批准号:
10373461 - 财政年份:2019
- 资助金额:
$ 14.08万 - 项目类别:
4/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
4/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
- 批准号:
10170530 - 财政年份:2019
- 资助金额:
$ 14.08万 - 项目类别:
4/5 The Cumulative Risk of Substance Exposure and Early Life Adversity on Child Health Development and Outcomes
4/5 物质暴露和早年不幸对儿童健康发展和结果的累积风险
- 批准号:
10018973 - 财政年份:2019
- 资助金额:
$ 14.08万 - 项目类别:
Translational Post-doctoral Training in Neurodevelopment
神经发育转化博士后培训
- 批准号:
9918451 - 财政年份:2017
- 资助金额:
$ 14.08万 - 项目类别:
Translational Post-doctoral Training in Neurodevelopment
神经发育转化博士后培训
- 批准号:
10178112 - 财政年份:2017
- 资助金额:
$ 14.08万 - 项目类别:
2/5-The Autism Biomarkers Consortium for Clinical Trials
2/5-自闭症生物标志物临床试验联盟
- 批准号:
10439669 - 财政年份:2015
- 资助金额:
$ 14.08万 - 项目类别:
相似海外基金
Mechanistic investigation into Frizzled-2 signaling for treatment of Osteogenesis Imperfecta
Frizzled-2 信号传导治疗成骨不全症的机制研究
- 批准号:
10680236 - 财政年份:2023
- 资助金额:
$ 14.08万 - 项目类别:
Synaptic dysglycosylation caused by the schizophrenia-risk variant in SLC39A8
SLC39A8 中精神分裂症风险变异引起的突触糖基化异常
- 批准号:
10671675 - 财政年份:2023
- 资助金额:
$ 14.08万 - 项目类别:
Neurocomputational Mechanisms of Affective Semantic Memory Development
情感语义记忆发展的神经计算机制
- 批准号:
10755053 - 财政年份:2023
- 资助金额:
$ 14.08万 - 项目类别:
Neurodevelopmental role of a tRNA methyltransferase underlying intellectual disability
tRNA 甲基转移酶对智力障碍的神经发育作用
- 批准号:
10540878 - 财政年份:2022
- 资助金额:
$ 14.08万 - 项目类别:
Examination of gut-microbiome-brain interactions in a novel gene x environment model of neurodevelopmental disorders
在神经发育障碍的新型基因 x 环境模型中检查肠道-微生物组-大脑相互作用
- 批准号:
10730191 - 财政年份:2022
- 资助金额:
$ 14.08万 - 项目类别: